Receptors, Interleukin-8B
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Receptors, Interleukin-8B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				High-affinity G-protein-coupled receptors for INTERLEUKIN-8 present on NEUTROPHILS; MONOCYTES; and T-LYMPHOCYTES. These receptors also bind several other CXC CHEMOKINES.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D023063
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D12.776.543.750.695.160.500.750.750 D12.776.543.750.705.852.125.500.750.750 D12.776.543.750.705.852.420.421.750 
						 | 
					
					
						| Concept/Terms | 
						
							Receptors, Interleukin-8B- Receptors, Interleukin-8B
 - Receptors, Interleukin 8B
 - Interleukin-8 Receptors Type B
 - Interleukin 8 Receptors Type B
 - Interleukin-8 Receptor Type B
 - Interleukin 8 Receptor Type B
 - Antigens, CDw128b
 - Interleukin-8B Receptor
 - Interleukin 8B Receptor
 - Receptor, Interleukin-8B
 - Receptors, CXCR2
 - CXCR2 Receptors
 - CXC Chemokine Receptor 2
 - CDw128b Antigens
 - Interleukin-8B Receptors
 - Interleukin 8B Receptors
 - CXCR2 Protein
 - Interleukin-8 Receptors B
 - Interleukin 8 Receptors B
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-8B".
				
					
						- Chemicals and Drugs [D]
 - Amino Acids, Peptides, and Proteins [D12]
 - Proteins [D12.776]
 - Membrane Proteins [D12.776.543]
 - Receptors, Cell Surface [D12.776.543.750]
 - Receptors, G-Protein-Coupled [D12.776.543.750.695]
 - Receptors, Chemokine [D12.776.543.750.695.160]
 - Receptors, CXCR [D12.776.543.750.695.160.500]
 - Receptors, Interleukin-8 [D12.776.543.750.695.160.500.750]
 - Receptors, Interleukin-8B [D12.776.543.750.695.160.500.750.750]
 - Receptors, Immunologic [D12.776.543.750.705]
 - Receptors, Cytokine [D12.776.543.750.705.852]
 - Receptors, Chemokine [D12.776.543.750.705.852.125]
 - Receptors, CXCR [D12.776.543.750.705.852.125.500]
 - Receptors, Interleukin-8 [D12.776.543.750.705.852.125.500.750]
 - Receptors, Interleukin-8B [D12.776.543.750.705.852.125.500.750.750]
 - Receptors, Interleukin [D12.776.543.750.705.852.420]
 - Receptors, Interleukin-8 [D12.776.543.750.705.852.420.421]
 - Receptors, Interleukin-8B [D12.776.543.750.705.852.420.421.750]
 
					
				 
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-8B".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Receptors, Interleukin-8B" by people in this website by year, and whether "Receptors, Interleukin-8B" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2000 | 0 | 1 | 1 | 
| 2002 | 0 | 1 | 1 | 
| 2015 | 1 | 0 | 1 | 
| 2019 | 1 | 0 | 1 | 
| 2020 | 0 | 1 | 1 | 
| 2021 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Receptors, Interleukin-8B" by people in Profiles.
						
					
								- 
								
Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients. Am J Transplant. 2021 11; 21(11):3714-3724.
															
								 
							
								- 
								
Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes. Diabetes Care. 2020 04; 43(4):710-718.
															
								 
							
								- 
								
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. Sci Transl Med. 2019 12 04; 11(521).
															
								 
							
								- 
								
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015 May 14; 125(20):3144-52.
															
								 
							
								- 
								
Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis. Cancer Res. 2009 Jan 01; 69(1):319-28.
															
								 
							
								- 
								
Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem. 2003 Feb 14; 278(7):4675-86.
															
								 
							
								- 
								
Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem. 2000 Mar 10; 275(10):6868-75.